Patents by Inventor Eric Hoopfer

Eric Hoopfer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reducing axon degeneration with proteasome inhibitors
    Patent number: 7238659
    Abstract: Reduced degeneration of an axon predetermined to be subject to degenerative neuropathy in a term patient is effected by contacting the axon in situ with an effective amount of a ubiquitin-proteasome system (UPS) inhibitor sufficient to reduce degeneration of the axon; and detecting a resultant reduction in the degeneration of the axon in situ.
    Type: Grant
    Filed: November 19, 2005
    Date of Patent: July 3, 2007
    Assignees: Children's Medical Center Corporation, The Board of Trustees of the Leland Stanford Junior University
    Inventors: Zhigang He, Qiwei Zhai, Jing Wang, Ryan Watts, Eric Hoopfer, Liqun Luo
  • Reducing axon degeneration with proteasome inhibitors
    Publication number: 20060074028
    Abstract: Reduced degeneration of an axon predetermined to be subject to degenerative neuropathy in a term patient is effected by contacting the axon in situ with an effective amount of a ubiquitin-proteasome system (UPS) inhibitor sufficient to reduce degeneration of the axon; and detecting a resultant reduction in the degeneration of the axon in situ.
    Type: Application
    Filed: November 19, 2005
    Publication date: April 6, 2006
    Inventors: Zhigang He, Qiwei Zhai, Jing Wang, Ryan Watts, Eric Hoopfer, Liqun Luo
  • Reducing axon degeneration with proteasome inhibitors
    Patent number: 7012063
    Abstract: Reduced degeneration of an axon predetermined to be subject to degenerative neuropathy in a term patient is effected by contacting the axon in situ with an effective amount of a ubiquitin-proteasome system (UPS) inhibitor sufficient to reduce degeneration of the axon; and detecting a resultant reduction in the degeneration of the axon in situ.
    Type: Grant
    Filed: June 13, 2003
    Date of Patent: March 14, 2006
    Assignee: Children's Medical Center Corporation
    Inventors: Zhigang He, Qiwei Zhai, Jing Wang, Ryan Watts, Eric Hoopfer, Liqun Luo
  • Reducing axon degeneration with proteasome inhibitors
    Publication number: 20040254118
    Abstract: Reduced degeneration of an axon predetermined to be subject to degenerative neuropathy in a term patient is effected by contacting the axon in situ with an effective amount of a ubiquitin-proteasome system (UPS) inhibitor sufficient to reduce degeneration of the axon; and detecting a resultant reduction in the degeneration of the axon in situ.
    Type: Application
    Filed: June 13, 2003
    Publication date: December 16, 2004
    Applicants: Children's Medical Center Corporation, The Board of Trustees for the Leland Stanford Jr. University
    Inventors: Zhigang He, Qiwei Zhai, Jing Wang, Ryan Watts, Eric Hoopfer, Liqun Luo